ライフサイエンスコーパス: spastic paraparesis

1 result in debilitating leukodystrophies and spastic paraparesis.

2 f 4 patients with HTLV-II seropositivity and spastic paraparesis.

3 ia and HTLV-1-associated myelopathy/tropical spastic paraparesis.

4 ma and HTLV-1-associated myelopathy/tropical spastic paraparesis.

5 tive motor neuron disorders characterized by spastic paraparesis.

6 progressive gait ataxia with a superimposed spastic paraparesis.

7 ia and HTLV-I-associated myelopathy/tropical spastic paraparesis.

8 ia and HTLV-1-associated myelopathy/tropical spastic paraparesis.

9 ia and HTLV-I-associated myelopathy/tropical spastic paraparesis.

10 in Reep1 null mice in addition to prominent spastic paraparesis.

11 sease, HTLV-I-associated myelopathy/tropical spastic paraparesis.

12 virus type I-associated myelopathy/tropical spastic paraparesis.

13 virus type I-associated myelopathy/tropical spastic paraparesis.

14 virus type I-associated myelopathy/tropical spastic paraparesis.

15 in three, with limb and gait ataxia and mild spastic paraparesis.

16 amilies affected by Alzheimer's disease with spastic paraparesis.

17 own as HTLV-I-associated myelopathy/tropical spastic paraparesis.

18 L) and HTLV-1-associated myelopathy/tropical spastic paraparesis.

19 emia and HTLV-I-associated myopathy/tropical spastic paraparesis.

20 ementia which is, in most cases, preceded by spastic paraparesis.

21 the pathology of HTLV-1-associated/tropical spastic paraparesis.

22 ma and HTLV-1-associated myelopathy-tropical spastic paraparesis.

23 und in HTLV-I-associated myelopathy/tropical spastic paraparesis.

24 d with HTLV-1-associated myelopathy/tropical spastic paraparesis?

25 is mutated, patients frequently present with spastic paraparesis, a thin corpus callosum, and cogniti

26 kemia virus-1-associated myelopathy/tropical spastic paraparesis, A6 also recognizes a self peptide f

27 ia and HTLV-1-associated myelopathy/tropical spastic paraparesis after the initial infection.

28 eases: HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T cell leukemia.

29 ed with a similar combination of progressive spastic paraparesis and polyneuropathy, variably associa

30 s with HTLV-1-associated myelopathy/tropical spastic paraparesis, and HTLV-1-associated uveitis.

31 M/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis), by reducing the proviral load of H

32 (CNS), HTLV-I-associated myelopathy/tropical spastic paraparesis, characterized pathologically by inf

33 isease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T cell leukemia/

34 rosis, HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) and chronic Lyme neuroborr

35 us 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS

36 pe 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS

37 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are known to be caused by

38 (HTLV) type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) based on newly developed m

39 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) exhibit reduced Foxp3 expr

40 ated (HTLV-I-associated) myelopathy/tropical spastic paraparesis (HAM/TSP) has been shown to be a maj

41 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic, progressive

42 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a neurological disease

43 pe 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a progressive inflammat

44 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immune-mediated infl

45 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory neurolo

46 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory neurolo

47 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is associated with immunor

48 L) and HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) is poorly understood.

49 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) proliferate spontaneously

50 s with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) results in a decrease in F

51 ent of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chronic inflammatory di

52 pe 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a disease that can be ind

53 evelop HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an immune-mediated disord

54 s with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), mono- or oligoclonal expa

55 ent of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), observed in up to 5% of i

56 L) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

57 L) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

58 termed HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

59 sorder HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

60 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

61 L) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

62 termed HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

63 ity of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

64 ropic virus I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

65 L) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

66 called HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

67 s with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

68 termed HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

69 associated myelopathy, also called tropical spastic paraparesis (HAM/TSP).

70 s with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

71 sease (HTLV-I-associated myelopathy/tropical spastic paraparesis [HAM/TSP]) is suggested to be an imm

72 virus type I-associated myelopathy/tropical spastic paraparesis has been reported and is thought to

73 We studied a case of Hereditary Spastic Paraparesis (HSP) in a single inbred Palestinian

74 alleles found in ex vivo samples of tropical spastic paraparesis-HTLV-1-associated myelopathy patient

75 segregation of different alleles in tropical spastic paraparesis-HTLV-associated myelopathy and ATLL

76 and the neurodegenerative disorder tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HA

77 adult T-cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy in abou

78 adult T-cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy, among

79 T-cell leukemia/lymphoma as well as tropical spastic paraparesis/HTLV-1-associated myelopathy.

80 agent for adult T-cell leukemia and tropical spastic paraparesis/HTLV-I-associated myelopathy.

81 kemia and the neurological disorder tropical spastic paraparesis/HTLV-I-associated myelopathy.

82 FR deficiency is a rare cause of complicated spastic paraparesis in adults, it should be considered i

83 ssociated myelopathy (also known as tropical spastic paraparesis), infective dermatitis of children a

84 virus type I-associated myelopathy/tropical spastic paraparesis is a chronic progressive inflammator

85 ype 1 (HTLV-1) -associated myelopathy/tropic spastic paraparesis is a demyelinating inflammatory neur

86 Spastic paraparesis is thought to be an occasional manif

87 identified novel clinical presentations with spastic paraparesis mimicking hereditary spastic paraple

88 , such as adult T-cell leukemia and tropical spastic paraparesis/myelopathy.

89 nia and parkinsonism (n = 1), and hereditary spastic paraparesis (n = 1).

90 clinical manifestations, including tropical spastic paraparesis or HTLV-1-associated myelopathy (TSP

91 a complicated form of adult-onset hereditary spastic paraparesis partially responsive to betaine ther

92 e of six HTLV-1-associated myelopathy/tropic spastic paraparesis patients carried a significant numbe

93 virus type I-associated myelopathy/tropical spastic paraparesis patients using real-time quantitativ

94 ropic virus I-associated myelopathy/tropical spastic paraparesis, rheumatoid arthritis, multiple scle

95 rmines HTLV-1-associated myelopathy/tropical spastic paraparesis risk.

96 Neurosensory hearing loss, ataxia, spastic paraparesis, sphincter dysfunction, somatosensor

97 s with HTLV-I-associated myelopathy/tropical spastic paraparesis suggest that HTLV-I may infect other

98 s with HTLV-1-associated myelopathy/tropical spastic paraparesis than in 29 asymptomatic carriers (80

99 HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP)] and subcortical ischaemic dam

100 d that HTLV-1-associated myelopathy/tropical spastic paraparesis was associated with a lower expressi

101 isease HTLV-1-associated myelopathy/tropical spastic paraparesis was associated with significantly in

102 sive neurodegenerative subtype of lower limb spastic paraparesis with additional diffuse skin and hai